Skip to main content
Livermore
Livermore
ZHEN

Exchange Traded Concepts, LLC

SEC CIK
0001457320
Latest filing
Aug 11, 2026

NBIX holding history

Neurocrine Biosciences Inc in every 13F filed by Exchange Traded Concepts, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NBIX overviewAll 13F holders of NBIXFull Q2 2026 holdings

Shares (Q2 2026)
4,268
Value
$719.3K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of NBIX by Exchange Traded Concepts, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20264,268$719.3K<0.1%+386+9.9%AddedHolders
Q1 20263,882$511.4K<0.1%−553−12.5%ReducedHolders
Q4 20254,435$629.0K<0.1%+2,641+147.2%AddedHolders
Q3 20251,794$251.8K<0.1%−5,369−75.0%ReducedHolders
Q2 20257,163$900.3K<0.1%+136+1.9%AddedHolders
Q1 20257,027$777.2K<0.1%−1,106−13.6%ReducedHolders
Q4 20248,133$1.11M<0.1%+169+2.1%AddedHolders
Q3 20247,964$917.6K<0.1%+1,803+29.3%AddedHolders
Q2 20246,161$848.2K<0.1%+429+7.5%AddedHolders
Q1 20245,732$790.6K<0.1%−1,479−20.5%ReducedHolders
Q4 20237,211$950.1K<0.1%+26+0.4%AddedHolders
Q3 20237,185$808.3K<0.1%−53−0.7%ReducedHolders
Q2 20237,238$682.5K<0.1%−222−3.0%ReducedHolders
Q1 20237,460$755.1K<0.1%−1,210−14.0%ReducedHolders
Q4 20228,670$1.04M<0.1%+147+1.7%AddedHolders
Q3 20228,523$905.0K<0.1%−429−4.8%ReducedHolders
Q2 20228,952$873.0K<0.1%+552+6.6%AddedHolders
Q1 20228,400$788.0K<0.1%−2,880−25.5%ReducedHolders
Q4 202111,280$961.0K<0.1%+5,130+83.4%AddedHolders
Q3 20216,150$590.0K<0.1%+5,610+1,038.9%AddedHolders
Q2 2021540$53.0K<0.1%−229−29.8%ReducedHolders
Q1 2021769$75.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.